Product Liability

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) lawsuit

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) lawsuit — Product Liability class action lawsuit

Case Overview

Depo-Provera, an injectable progestin-based contraceptive manufactured by Pfizer's Pharmacia & Upjohn subsidiary, has been widely used by millions of women worldwide since its FDA approval in 1992. In 2024, a landmark French study published in the British Medical Journal found that long-term use of medroxyprogesterone acetate (the active ingredient in Depo-Provera) was associated with a more than five-fold increased risk of developing meningioma — a type of brain tumor that grows on the protective membranes surrounding the brain and spinal cord. France's drug regulator moved to restrict the drug's use, and the FDA updated the Depo-Provera label in 2024 to add a warning about the meningioma risk.xPlaintiffs allege that Pfizer knew or should have known about the link between prolonged Depo-Provera use and meningioma development long before the label was updated, and that the company failed to adequately warn patients or healthcare providers. The lawsuits assert claims of strict products liability (failure to warn and design defect), negligence, fraudulent misrepresentation, and breach of warranty. Many plaintiffs required brain surgery to remove meningiomas after years of Depo-Provera use. The litigation is rapidly growing, with thousands of individual cases filed in federal courts across the country and efforts underway to consolidate cases into a multidistrict litigation (MDL).

Federal cases are centralized in a Multidistrict Litigation (MDL No. 3140) in the Northern District of Florida under Judge M. Casey Rodgers. Over 6,500 federal lawsuits have been filed.

A private settlement agreement has emerged, and eligible claimants have a registration deadline of November 30, 2026.

Projected settlement values often range from $100,000 to over $500,000+ depending on the severity of the tumor, required surgeries, and extent of medical damages. Payments are expected to begin in early 2027

Who May Qualify

You may be eligible if you used Depo-Provera (injectable medroxyprogesterone acetate) for six months or more and were subsequently diagnosed with a meningioma brain tumor. Women who underwent surgery, radiation, or other treatment for the tumor may have stronger claims.

Frequently Asked Questions

Does Depo-Provera really cause brain tumors?

A major 2024 study in the British Medical Journal found that long-term Depo-Provera use (injectable medroxyprogesterone) was associated with a significantly elevated risk of meningioma brain tumors, leading the FDA to update the drug's warning label.

How do I know if my meningioma was caused by Depo-Provera?

If you used Depo-Provera for an extended period and were later diagnosed with a meningioma, you should consult an attorney. Medical and scientific experts can help establish a causal link based on your specific medical history and duration of use.

Is there an MDL for Depo-Provera lawsuits?

As of 2025, courts were considering consolidation of the growing number of Depo-Provera cases into a federal multidistrict litigation. The case count has grown rapidly following the 2024 BMJ study and FDA label update.

Related Cases

Toyota Hybrid Inverter Defect Lawsuit — Product Liability class action lawsuit

Toyota Hybrid Inverter Defect Lawsuit

Current
Product Liability
A class action lawsuit has been filed against Toyota concerning alleged dangerous defects in the hybrid inverter components of certain Corolla and Camry models. The plaintiff claims Toyota knowingly sold these vehicles with a defect before issuing a recall.
Honda Keyless Entry System Theft Vulnerability Lawsuit — Product Liability class action lawsuit

Honda Keyless Entry System Theft Vulnerability Lawsuit

Current
Product Liability
A class action lawsuit has been filed alleging that Honda vehicles equipped with passive keyless entry systems are susceptible to theft due to undisclosed vulnerabilities. The plaintiff claims the company engaged in deceptive trade practices by failing to disclose these security flaws to consumers.
GM Class Action Lawsuit Over Defective Brake Cylinder Assemblies — Product Liability class action lawsuit

GM Class Action Lawsuit Over Defective Brake Cylinder Assemblies

Current
Product Liability
General Motors is facing a class action lawsuit concerning vehicles that allegedly had defective master brake cylinder assemblies. The suit specifically names certain model years of Chevrolet, GMC, Buick, and Colorado vehicles.